Incidence of neutropenia induced by chemotherapy in the treatment of colorectal cancer

Abstract

Results: 499 articles were identified, of which 15 met the criteria for inclusion, published between 2006 and 2016 and analyzed in their entirety. Neutropenia was the most reported hematologic toxicity in 12 (80.0%) studies, and the second most common in three (20.0%), in varying degrees, being responsible for reducing and/or delaying of doses in six (40.0%) studies. Conclusion: the studies included in this review showed that neutropenia in patients with colorectal cancer in chemotherapy treatment have low incidences in different degrees, despite the significantly high rates of neutropenia associations, as the most common adverse event in the various analyzed regimes.

Neutropenia em pacientes com câncer colorretal submetidos a tratamento quimioterápico adjuvante / Neutropenia in patients with colorretal cancer undergoing adjuvant chemotherapy treatment

“…Contudo, cabe também ao enfermeiro, a busca constante pelo conhecimento em sua área de atuação, a fim de adquirir habilidades psicomotoras, conhecimento científico sobre a ação dos agentes quimioterápicos e o preparo do paciente e familiar por ele assistidos, contribuindo para a prestação de uma assistência de enfermagem resolutiva e de qualidade, obtendo sucesso nos resultados finais do tratamento e, consequentemente diminuindo a ocorrência de atrasos, reduções de dose, suspensão e/ou abandono do tratamento (BARBOSA et al, 2019;BARBOSA et al, 2020).…”